Related references
Note: Only part of the references are listed.Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial
Tom Holvoet et al.
GASTROENTEROLOGY (2021)
FMT in IBS: how cautious should we be?
Magdy El-Salhy
GUT (2021)
Changes in fecal short-chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome
Magdy El-Salhy et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2021)
Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis
Theodore Rokkas et al.
GASTROENTEROLOGY (2021)
Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome
Magdy El-Salhy et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21st century
Magdy El-Salhy et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study
Magdy El-Salhy et al.
GUT (2020)
Letter: faecal microbiota transplantation for IBS
Jonathan P. Segal et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Letter: faecal microbiota transplantation for irritable bowel syndrome-room for improvement
Gianluca Ianiro et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome
Yoshiyuki Mishima et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Alterations in fecal short-chain fatty acids in patients with irritable bowel syndrome A systematic review and meta-analysis
Qinghua Sun et al.
MEDICINE (2019)
Clostridium ramosum regulates enterochromaffin cell development and serotonin release
Ana D. Mandic et al.
SCIENTIFIC REPORTS (2019)
Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome
Gianluca Ianiro et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
A network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in recurrent Clostridium difficile infection
Theodore Rokkas et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2019)
The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study
Savanne Holster et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2019)
Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS)
Magdy El-Salhy et al.
NUTRIENTS (2019)
Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial
Olga C. Aroniadis et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
Zachariah DeFilipp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Fecal Microbiota Transplantation for Dysbiosis - Predictable Risks
Martin J. Blaser
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
Dabo Xu et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study
Sofie Ingdam Halkjaer et al.
GUT (2018)
Fecal microbiota transplantation for managing irritable bowel syndrome
Magdy El-Salhy et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2018)
Efficacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: A systematic review and meta-analysis
Gianluca Ianiro et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2018)
A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome
Joanna Dionne et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial
Peter Holger Johnsen et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome
Julien Tap et al.
GASTROENTEROLOGY (2017)
Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease
Magdy El-Salhy et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
What Is New in Rome IV
Max J. Schmulson et al.
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2017)
Irritable bowel syndrome: a gut microbiota-related disorder?
Yogesh Bhattarai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2017)
Pathophysiology of irritable bowel syndrome
Gerald J. Holtmann et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
Brian Hutton et al.
ANNALS OF INTERNAL MEDICINE (2015)
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
Jessica M. Yano et al.
CELL (2015)
Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States
Anne F. Peery et al.
GASTROENTEROLOGY (2015)
Irritable Bowel Syndrome A Clinical Review
William D. Chey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Recent developments in the pathophysiology of irritable bowel syndrome
Magdy El-Salhy
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
The association between Helicobacter pylori infection and inflammatory bowel disease based on meta-analysis
T. Rokkas et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2015)
Characteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria
A. C. Ford et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Evaluating the Quality of Evidence from a Network Meta-Analysis
Georgia Salanti et al.
PLOS ONE (2014)
A Microsoft-Excel-based tool for running and critically appraising network meta-analyses-an overview and application of NetMetaXL
Stephen Brown et al.
SYSTEMATIC REVIEWS (2014)
Graphical Tools for Network Meta-Analysis in STATA
Anna Chaimani et al.
PLOS ONE (2013)
5-Hydroxytryptamine (serotonin) in the gastrointestinal tract
Michael D. Gershon
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2013)
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
Rebecca M. Lovell et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome
I. M. Carroll et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2012)
Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome
Ian M. Carroll et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
Georgia Salanti et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Gut hormones: emerging role in immune activation and inflammation
W. I. Khan et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
The serotonin signaling system: From basic understanding to drug development-for functional GI disorders
Michael D. Gershon et al.
GASTROENTEROLOGY (2007)
Systematic review - natural history of irritable bowel syndrome
HB El-Serag et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
The impact of irritable bowel syndrome on health-related quality of life
IM Gralnek et al.
GASTROENTEROLOGY (2000)